JESSICA HALL: Open Payments
NPI 1194165399 · LAKESIDE PARK, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 26 payments from 11 companies in 2025. Trend: 2023 $769 · 2024 $433 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $227 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Novo Nordisk Inc | 5 | $99 |
| Exact Sciences Corporation | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: UBRELVY, AIRSUPRA, VRAYLAR, Ozempic, Cologuard Collection Kit, JARDIANCE, Auvelity, Wegovy.
Industry payments across KY — which companies pay providers there.
